GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Arich Enterprise Co Ltd (ROCO:4173) » Definitions » EV-to-EBIT

Arich Enterprise Co (ROCO:4173) EV-to-EBIT : 8.41 (As of May. 27, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Arich Enterprise Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Arich Enterprise Co's Enterprise Value is NT$873 Mil. Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$104 Mil. Therefore, Arich Enterprise Co's EV-to-EBIT for today is 8.41.

The historical rank and industry rank for Arich Enterprise Co's EV-to-EBIT or its related term are showing as below:

ROCO:4173' s EV-to-EBIT Range Over the Past 10 Years
Min: 4.64   Med: 21.51   Max: 103.12
Current: 8.41

During the past 13 years, the highest EV-to-EBIT of Arich Enterprise Co was 103.12. The lowest was 4.64. And the median was 21.51.

ROCO:4173's EV-to-EBIT is ranked better than
83.22% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 17.65 vs ROCO:4173: 8.41

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Arich Enterprise Co's Enterprise Value for the quarter that ended in Mar. 2024 was NT$981 Mil. Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was NT$104 Mil. Arich Enterprise Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was 10.58%.


Arich Enterprise Co EV-to-EBIT Historical Data

The historical data trend for Arich Enterprise Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arich Enterprise Co EV-to-EBIT Chart

Arich Enterprise Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16.85 22.85 12.35 9.66 13.97

Arich Enterprise Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.97 15.11 15.01 13.97 9.45

Competitive Comparison of Arich Enterprise Co's EV-to-EBIT

For the Pharmaceutical Retailers subindustry, Arich Enterprise Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arich Enterprise Co's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Arich Enterprise Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Arich Enterprise Co's EV-to-EBIT falls into.



Arich Enterprise Co EV-to-EBIT Calculation

Arich Enterprise Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=873.309/103.847
=8.41

Arich Enterprise Co's current Enterprise Value is NT$873 Mil.
Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arich Enterprise Co  (ROCO:4173) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Arich Enterprise Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 ) =EBIT / Enterprise Value (Q: Mar. 2024 )
=103.847/981.4409
=10.58 %

Arich Enterprise Co's Enterprise Value for the quarter that ended in Mar. 2024 was NT$981 Mil.
Arich Enterprise Co's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$104 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Arich Enterprise Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Arich Enterprise Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Arich Enterprise Co (ROCO:4173) Business Description

Traded in Other Exchanges
N/A
Address
No.880, Zhongzheng Road, 14F-5, Zhonghe District, Taipei, TWN, 235601
Arich Enterprise Co Ltd is a Taiwan-based company operating in the pharmaceutical industry. The company is engaged in providing medical sales and promotion and logistics services. The company markets and sells pharmaceutical products. The company's services cover customers including medical centers, area hospitals, district hospitals, general practitioner, and key accounts which includes chain stores and hyper markets, drug stores, and wholesalers. The product portfolio of the company includes Actos, Aftach, Cytotec, Gaster, Prometin, Hicee, Lederscon, Alinamin, Nacid tab, Setoral, Sibutil, and many more.

Arich Enterprise Co (ROCO:4173) Headlines

No Headlines